Fig. 4 | Scientific Reports

Fig. 4

From: CH7450924, a KEAP1-NRF2 interaction inhibitor, ameliorates LPS-induced multiple organ dysfunction via inflammatory pathway inhibition

Fig. 4

Effects of CH7450924 on lung injury in MODS model induced by intratracheal LPS injection. (A) mRNA expression of IL-6, IL-1β in the lung, (B) lung wet weight, (C) representative HE-stained lung sections from NC, DC, and CH0924 (20 mg/kg) groups, (D) semi-quantitative analysis of neutrophil infiltration of alveoli and thickening of alveolar wall, (E) mRNA expression of SFTPC in lung, and (F) SpO2 monitored using infrared pulse oximetry. CH7450924 was administered at 5, 10, or 20 mg/kg twice a day before and after LPS injection. The actual values are represented as dots, and the bars represent mean ± SE (NC: n = 3 or 4, others: n = 8 or 9). *p < 0.05, significant difference versus vehicle-treated LPS mice (Student’s t-test). #p < 0.05, significant difference between NC and DC (Student’s t-test). *p < 0.05, significant difference between DC and CH7450924 (William’s t-test). BR, Bronchiole, NC; Normal control, DC; Disease control, CH0924; CH7450924.

Back to article page